Home
Market Capitalization of Sharon Bio-medicine Ltd

Sharon Bio-Medicine Ltd
NSE: SHARONBIO
Market Cap
Key Highlights
- The Market Cap of Sharon Bio-Medicine Ltd is ₹ 38.18 crore as of 28 Mar 19 .
- The Latest Trading Price of Sharon Bio-Medicine Ltd is ₹ 3.21 as of 28 Mar 15:30 .
- The Dividend Payouts of Sharon Bio-Medicine Ltd is ₹ 0.36 as of Dec 11, 2014 .

Sharon Bio-Medicine Ltd
NSE: SHARONBIO
Share Price
Market Price of Sharon Bio-Medicine Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Mar 2019 | 3.21 |
27 Mar 2019 | 3.26 |
26 Mar 2019 | 3.43 |
25 Mar 2019 | 3.61 |
22 Mar 2019 | 3.79 |
20 Mar 2019 | 3.98 |
19 Mar 2019 | 4.17 |
18 Mar 2019 | 4.37 |
15 Mar 2019 | 4.43 |
14 Mar 2019 | 4.22 |
BlinkX Score for Sharon Bio-Medicine Ltd
Asset Value vs Market Value of Sharon Bio-Medicine Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Sharon Bio-Medicine Ltd
Historical P/E Ratio of Sharon Bio-Medicine Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sharon Bio-Medicine Ltd
Historical Revenue of Sharon Bio-Medicine Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Sharon Bio-Medicine Ltd
Historical EBITDA of Sharon Bio-Medicine Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sharon Bio-Medicine Ltd
Historical Net Profit of Sharon Bio-Medicine Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd
NSE: SHARONBIO
DIVIDENDPAYOUT
About Sharon Bio-Medicine Ltd
- Incorporated in 1989,Sharon Bio-Medicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient (API), intermediates and formulations.
- During the fiscal year ended June 30, 2010, it had set up an active pharmaceutical ingredients plant in Taloja near Navi Mumbai.The company had installed capacity of 150,000 liters of reactors capacity of API and intermediates, and 2.5 billion tablets per shift per annum and one billion capsules per shift per annum.
- Its products include Trimetazidine Di Hydrochloride, Ketoconzole, Pentaprazole, Amlodipine Besylate, Atomoxetine Hcl, Carisoprodl, Closantel Base, Glimepiride, Ketoconazole, Nifedipibe, Racecadotril, Toldimfos, Telmisartan, Tamsulosin, Itraconazole, Mesalazine, Lansoprazole and Doxorubicin Inj.